Literature DB >> 20818823

Gastrojejunostomy followed by induction chemotherapy for incurable gastric cancer with outlet obstruction.

Yasuhiro Okumura1, Manabu Ohashi, Souya Nunobe, Tomohiro Iwanaga, Tatsuo Kanda, Yoshiaki Iwasaki.   

Abstract

A 72-year-old male gastric cancer patient with outlet obstruction underwent laparoscopic exploration. The examination disclosed intraperitoneal free cancer cells with no overt peritoneal, lymphatic, or hepatic metastasis. The patient underwent laparoscopy-assisted gastrojejunostomy (LAGJ) and started chemotherapy with S-1 plus cisplatin on postoperative day 13. Three course of the chemotherapy shrank the tumor markedly. Then, the patient underwent gastrectomy with a curative intent. Laparotomy revealed no intraperitoneal free cancer cells, and microscopically complete resection was achieved. The patient received S-1 chemotherapy as postoperative adjuvant treatment for 1 year, and is still alive with no evidence of peritoneal recurrence. LAGJ followed by S-1 plus cisplatin is one of the optional treatments that should be considered for patients with outlet obstruction as it may widen opportunities for potentially curative resection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818823      PMCID: PMC2937120          DOI: 10.3748/wjg.v16.i34.4367

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.

Authors:  Eiji Ako; Masaichi Ohira; Yoshito Yamashita; Naoshi Kubo; Kazuya Muguruma; Masakazu Yashiro; Tetsuji Sawada; Bunzo Nakata; Yasuyuki Kato; Kosei Hirakawa
Journal:  Hepatogastroenterology       Date:  2008 Sep-Oct

2.  Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer.

Authors:  Manabu Ohashi; Tatsuo Kanda; Masaki Hirota; Takashi Kobayashi; Kazuhito Yajima; Shin-ichi Kosugi; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

3.  Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination.

Authors:  Seiji Satoh; Suguru Hasegawa; Nobuhiro Ozaki; Hiroshi Okabe; Go Watanabe; Satoshi Nagayama; Masanori Fukushima; Arimichi Takabayashi; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

4.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

5.  Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer.

Authors:  Satoru Nakagawa; Atsushi Nashimoto; Hiroshi Yabusaki
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

6.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

7.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

8.  Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer.

Authors:  T Boku; Y Nakane; T Minoura; H Takada; M Yamamura; K Hioki; M Yamamoto
Journal:  Br J Surg       Date:  1990-04       Impact factor: 6.939

9.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

Review 10.  Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review.

Authors:  Suzanne M Jeurnink; Casper H J van Eijck; Ewout W Steyerberg; Ernst J Kuipers; Peter D Siersema
Journal:  BMC Gastroenterol       Date:  2007-06-08       Impact factor: 3.067

View more
  2 in total

1.  Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.

Authors:  Yasuhiro Okumura; Hiroharu Yamashita; Susumu Aikou; Koichi Yagi; Yukinori Yamagata; Masato Nishida; Kazuhiko Mori; Sachiyo Nomura; Joji Kitayama; Toshiaki Watanabe; Yasuyuki Seto
Journal:  World J Surg Oncol       Date:  2014-11-29       Impact factor: 2.754

2.  Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.

Authors:  Xiao-Jiang Chen; Guo-Ming Chen; Yi-Cheng Wei; Hong Yu; Xi-Cheng Wang; Zhou-Kai Zhao; Tian-Qi Luo; Run-Cong Nie; Zhi-Wei Zhou
Journal:  BMC Cancer       Date:  2021-02-23       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.